These changes had important implications on the sensitivity of the breast cancer model; mice treated with a combination of immunotherapies directed at both PD-1 and CTLA-4 as well as scripted exercise had delayed tumor growth and decreased tumor volume compared to sedentary mice. Here, CTLA4 is linked to breast cancer.